Location: Boston, MA
Brent Henry will be moderating and Bethany Hills will be speaking on a panel entitled "Standards and Regulation: The Emerging AI Framework" at the Partners HealthCare World Medical Innovation Forum.
As the health care industry faces an explosion of AI-based tools, the FDA’s approach to these technologies is evolving. This session will focus on the agency’s approach to AI-based products, how to calculate the risk profile of these new technologies, and the challenges of securing adequate data rights.
Brent Henry, Member, Mintz
Bethany Hills, Member/ Chair, FDA Practice, Mintz
Michelle McMurry-Heath, MD, PhD, VP, Global Regulatory Affairs and International Clinical Evidence, Johnson & Johnson Medical Devices
Bakul Patel, Associate Director, Digital Health, FDA
Michael Spadafore, Managing Director, Sandbox Industries